[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-427505-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-427505-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","continuity-of-visiting-pharmacist-services-for-older-adults-with-and-without-terminal-cancer-in-japan","CONTINUITY OF VISITING PHARMACIST SERVICES FOR OLDER ADULTS WITH AND WITHOUT TERMINAL CANCER IN JAPAN","","Homebound older adults often face polypharmacy and complex medication regimens. Visiting pharmacist services support in-home medication management, yet evidence on service continuity remains limited. This retrospective cohort study examined continuity and reasons for cessation among homebound adults aged ≥65 in Japan, stratified by terminal cancer status, using medical and long-term care claims for those initiating services between 2014 and 2019.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/continuity-of-visiting-pharmacist-services-for-older-adults-with-and-without-terminal-cancer-in-japan/427505/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/continuity-of-visiting-pharmacist-services-for-older-adults-with-and-without-terminal-cancer-in-japan/427505.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-22","2026-09-29",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study aim regarding visiting pharmacist services?","Question",{"text":63,"@type":64},"The study examined the continuity of visiting pharmacist services and the reasons for service cessation among homebound older adults, stratified by terminal cancer status.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were service cessation and participant follow-up defined?",{"text":68,"@type":64},"Participants were followed until service cessation, defined as no service claims for two consecutive months, or until 12 months from initiation.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main differences in continuity between those with and without terminal cancer?",{"text":72,"@type":64},"The median time to any-cause cessation was 2 months for participants with terminal cancer, while 51.9% of those without terminal cancer remained event-free at the end of the study. Death was the most common reason, and 12-month cumulative incidence was more than four times higher for those with terminal cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},427505,1790792917,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":22,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":30},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","792 Innovation in Aging, 2025, Vol. 9, No. S2  \nAbstract citation ID: igaf122.2687  \nCONTINUITY OF VISITING PHARMACIST SERVICES  \nFOR OLDER ADULTS WITH AND WITHOUT  \nTERMINAL CANCER IN JAPAN  \nReina Taguchi1, Akira Okada2, Rumiko Tsuchiya-Ito3, Satomi Kitamura1, Tomoki Ishikawa1, and Shota Hamada1, 1. Institute for Health Economics and Policy, Association for Health Economics Research and Social Insurance and Welfare, Tokyo, Tokyo, Japan, 2. The University of Tokyo, Tokyo, Tokyo, Japan, 3. Dia Foundation for Research on Ageing Societies, Tokyo, Tokyo, Japan  \nHomebound older adults often experience polypharmacy and complex medication regimens. Visiting pharmacist services, which support in-home medication management, have been reported to help optimize medication use, but little is known about their continuity. This study aimed to examine the continuity of visiting pharmacist service and reasons for cessation ina homebound older population in Japan stratified by terminal cancer status. This retrospective cohort study used medical and long-term care claims data from older adults aged ≥65 years in Hachioji-city of Tokyo, Japan, who began to receive visiting pharmacist services between April 2014 and March 2019.  \nParticipants were followed until service cessation (absence of service claims for two consecutive months) or 12 months from initiation. Reasons for cessation were categorized into death, relocation, hospitalization/institutionalization, or discontinuation. The study included 3,952 participants, with 353 (8.9%) having terminal cancer. The median time to any-cause cessation was 2 months for participants with terminal cancer, while 51.9% of those without terminal cancer remained event-free at study end. Death was the most common reason, but the 12-month cumulative incidence for participants with terminal cancer was more than four times higher. For individuals with terminal cancer, the service typically begins months before death, requiring pharmacists to adapt to condition changes. Those without cancer often use the service for over a year, necessitating routine medication review. These findings will help pharmacists tailor care to individual patient needs and expected service duration. They can also guide countries considering similar services in response to aging populations and healthcare shortages.","cbCaia3HkJAlbsjJ","https://ap.wps.com/l/cbCaia3HkJAlbsjJ","pdf",713817,"English","# Study objective and design\n## Participants and follow-up\n## Cessation outcomes and reasons\n## Key findings and implications","[{\"question\":\"What was the study aim regarding visiting pharmacist services?\",\"answer\":\"The study examined the continuity of visiting pharmacist services and the reasons for service cessation among homebound older adults, stratified by terminal cancer status.\"},{\"question\":\"How were service cessation and participant follow-up defined?\",\"answer\":\"Participants were followed until service cessation, defined as no service claims for two consecutive months, or until 12 months from initiation.\"},{\"question\":\"What were the main differences in continuity between those with and without terminal cancer?\",\"answer\":\"The median time to any-cause cessation was 2 months for participants with terminal cancer, while 51.9% of those without terminal cancer remained event-free at the end of the study. Death was the most common reason, and 12-month cumulative incidence was more than four times higher for those with terminal cancer.\"}]","CONTINUITY OF VISITING PHARMACIST SERVICES FOR OLDER ADULTS WITH AND WITHOUT TERMINAL CANCER IN JAPAN | PDF",1790644037]